Tyler Dylan Hyde Crispr Therapeutics Ag (CRSP) insider trading activity

CRSP Quotes by TradingView

Tyler Dylan Hyde is Chief Legal Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 25,204 shares of CRSP, which is worth approximately $1.27 Million. The most recent transaction as insider was on Jan 16, 2018, when has been sold 66,000 shares (Common Shares) at a price of $28.11 per share, resulting in proceeds of $1,855,260. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.2K
0% 3M change
0% 12M change
Total Value Held $1.27 Million

Tyler Dylan-Hyde Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 16 2018
SELL
Open market or private sale
$1,855,260 $28.11 p/Share
66,000 Reduced 72.37%
25,204 Common Shares
Jan 16 2018
BUY
Exercise of conversion of derivative security
$263,970 $12.57 p/Share
21,000 Added 31.77%
45,094 Common Shares
Jan 02 2018
SELL
Open market or private sale
$879,700 $23.15 p/Share
38,000 Reduced 35.12%
70,204 Common Shares
Jan 02 2018
BUY
Exercise of conversion of derivative security
$100,560 $12.57 p/Share
8,000 Added 9.28%
78,204 Common Shares
Dec 29 2017
SELL
Open market or private sale
$681,447 $22.49 p/Share
30,300 Reduced 23.22%
100,204 Common Shares
Dec 29 2017
BUY
Exercise of conversion of derivative security
$206,550 $13.5 p/Share
15,300 Added 10.96%
124,274 Common Shares
Dec 28 2017
SELL
Open market or private sale
$15,225 $21.75 p/Share
700 Reduced 0.6%
115,204 Common Shares
Dec 28 2017
BUY
Exercise of conversion of derivative security
$10,101 $14.43 p/Share
700 Added 0.6%
115,904 Common Shares
Dec 22 2017
SELL
Open market or private sale
$308,250 $20.55 p/Share
15,000 Reduced 11.52%
115,204 Common Shares
Dec 15 2017
SELL
Open market or private sale
$283,500 $18.9 p/Share
15,000 Reduced 10.33%
130,204 Common Shares
Aug 08 2017
SELL
Open market or private sale
$24,422 $18.6 p/Share
1,313 Reduced 0.85%
153,204 Common Shares
Aug 07 2017
SELL
Open market or private sale
$245,178 $18.56 p/Share
13,210 Reduced 7.88%
154,517 Common Shares
Aug 04 2017
SELL
Open market or private sale
$8,848 $18.55 p/Share
477 Reduced 0.28%
167,727 Common Shares
May 01 2017
SELL
Open market or private sale
$30,762 $16.61 p/Share
1,852 Reduced 1.09%
168,204 Common Shares
Apr 28 2017
SELL
Open market or private sale
$81,637 $16.62 p/Share
4,912 Reduced 2.81%
170,056 Common Shares
Apr 27 2017
SELL
Open market or private sale
$227,795 $16.84 p/Share
13,527 Reduced 7.18%
174,968 Common Shares
Apr 26 2017
SELL
Open market or private sale
$53,632 $16.76 p/Share
3,200 Reduced 1.74%
180,495 Common Shares
Apr 25 2017
SELL
Open market or private sale
$80,976 $16.87 p/Share
4,800 Reduced 2.55%
183,695 Common Shares
Apr 24 2017
SELL
Open market or private sale
$57,902 $16.44 p/Share
3,522 Reduced 1.83%
188,495 Common Shares
Apr 21 2017
SELL
Open market or private sale
$51,230 $17.02 p/Share
3,010 Reduced 1.54%
192,017 Common Shares
Apr 20 2017
SELL
Open market or private sale
$51,016 $17.37 p/Share
2,937 Reduced 1.48%
195,027 Common Shares
Apr 19 2017
SELL
Open market or private sale
$130,610 $18.04 p/Share
7,240 Reduced 3.53%
197,964 Common Shares
TD

Tyler Dylan Hyde

Chief Legal Officer
6300 Zug, V8

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRSP